Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer's disease: Targeting the Cholinergic System
Talita H. Ferreira‐Vieira, Isabella G. Olmo, Flávia Rodrigues da Silva, et al.
Current Neuropharmacology (2016) Vol. 14, Iss. 1, pp. 101-115
Open Access | Times Cited: 1282

Showing 1-25 of 1282 citing articles:

Comprehensive Review on Alzheimer’s Disease: Causes and Treatment
Zeinab Breijyeh, Rafik Karaman
Molecules (2020) Vol. 25, Iss. 24, pp. 5789-5789
Open Access | Times Cited: 1858
The Effects of Acute Exercise on Mood, Cognition, Neurophysiology, and Neurochemical Pathways: A Review
Julia C. Basso, Wendy Suzuki
Brain Plasticity (2017) Vol. 2, Iss. 2, pp. 127-152
Open Access | Times Cited: 698
History and progress of hypotheses and clinical trials for Alzheimer’s disease
Peipei Liu, Yi Xie, Xiao‐Yan Meng, et al.
Signal Transduction and Targeted Therapy (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 573
Regulation of Neurotransmitters by the Gut Microbiota and Effects on Cognition in Neurological Disorders
Yijing Chen, Jinying Xu, Yu Chen
Nutrients (2021) Vol. 13, Iss. 6, pp. 2099-2099
Open Access | Times Cited: 543
Recent Advancements in Pathogenesis, Diagnostics and Treatment of Alzheimer’s Disease
Sahil Khan, Kalyani Barve, Maushmi S. Kumar
Current Neuropharmacology (2020) Vol. 18, Iss. 11, pp. 1106-1125
Open Access | Times Cited: 530
Role of Plant Derived Alkaloids and Their Mechanism in Neurodegenerative Disorders
Ghulam Hussain, Azhar Rasul, Haseeb Anwar, et al.
International Journal of Biological Sciences (2018) Vol. 14, Iss. 3, pp. 341-357
Open Access | Times Cited: 280
Pathological mechanisms and therapeutic strategies for Alzheimer’s disease
Kin Yip Tam, Yaojun Ju
Neural Regeneration Research (2021) Vol. 17, Iss. 3, pp. 543-543
Open Access | Times Cited: 262
Alzheimer’s Disease Pharmacotherapy in Relation to Cholinergic System Involvement
Gabriela Dumitriṭa Stanciu, Andrei Luca, Răzvan Nicolae Rusu, et al.
Biomolecules (2019) Vol. 10, Iss. 1, pp. 40-40
Open Access | Times Cited: 225
Heme Cofactor‐Resembling Fe–N Single Site Embedded Graphene as Nanozymes to Selectively Detect H2O2 with High Sensitivity
Min Su Kim, Junsang Lee, Hye Su Kim, et al.
Advanced Functional Materials (2019) Vol. 30, Iss. 1
Closed Access | Times Cited: 217
Impact of Natural Compounds on Neurodegenerative Disorders: From Preclinical to Pharmacotherapeutics
Mehdi Sharifi‐Rad, Chintha Lankatillake, Daniel A. Dias, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 4, pp. 1061-1061
Open Access | Times Cited: 213
The Cholinergic System Modulates Memory and Hippocampal Plasticity via Its Interactions with Non-Neuronal Cells
Sara V. Maurer, Christina L. Williams
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 211
Tau protein aggregation in Alzheimer's disease: An attractive target for the development of novel therapeutic agents
Marie Jouanne, Sylvain Rault, Anne Sophie Voisin‐Chiret
European Journal of Medicinal Chemistry (2017) Vol. 139, pp. 153-167
Closed Access | Times Cited: 210
Multi-target design strategies for the improved treatment of Alzheimer's disease
Pengfei Zhang, Shengtao Xu, Zheying Zhu, et al.
European Journal of Medicinal Chemistry (2019) Vol. 176, pp. 228-247
Open Access | Times Cited: 197
Neuroprotective Effect of SGLT2 Inhibitors
Agnieszka Pawlos, Marlena Broncel, Ewelina Woźniak, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7213-7213
Open Access | Times Cited: 175
Pushing the frontiers: tools for monitoring neurotransmitters and neuromodulators
Zhaofa Wu, Dayu Lin, Yulong Li
Nature reviews. Neuroscience (2022) Vol. 23, Iss. 5, pp. 257-274
Closed Access | Times Cited: 163
The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers
Kim San Tang
Life Sciences (2019) Vol. 233, pp. 116695-116695
Open Access | Times Cited: 161
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 156
GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment
Yilan Xu, Man-Na Zhao, Yuying Han, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 155
Neuroprotective Natural Products for Alzheimer’s Disease
Xin Chen, Joshua Adam Drew, Wren Berney, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1309-1309
Open Access | Times Cited: 152
Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses
Botond Antal, Liam McMahon, Syed Fahad Sultan, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 135
Microbial-derived metabolites as a risk factor of age-related cognitive decline and dementia
Emily Connell, Gwénaëlle Le Gall, Matthew G. Pontifex, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 129
The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain
Anna Gąsiorowska, Małgorzata Wydrych, Patrycja Drapich, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 118
The Cholinergic System, the Adrenergic System and the Neuropathology of Alzheimer’s Disease
Rola A. Bekdash
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1273-1273
Open Access | Times Cited: 117
The State of The Art on Acetylcholinesterase Inhibitors in the Treatment of Alzheimer’s Disease
Immacolata Vecchio, Luca Sorrentino, Anna Maria Paoletti, et al.
Journal of Central Nervous System Disease (2021) Vol. 13
Open Access | Times Cited: 111
Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s disease
Pritam Thapa, Sunil P. Upadhyay, William Z. Suo, et al.
Bioorganic Chemistry (2021) Vol. 108, pp. 104681-104681
Open Access | Times Cited: 106
Page 1 - Next Page

Scroll to top